Reduced Asthma Exacerbations and Asthma-Related Healthcare Resource Use With Omalizumab From the Real-World PROSPERO Study

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.303
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV